European Haemophilia Consortium: Day 1 At EHC Conference 2025 In Vienna – What A Start
European Haemophilia Consortium (EHC) posted on LinkedIn:
”Day 1 at EHC Conference 2025 in Vienna – What a Start
We kicked off with insights into haemophilia care in Austria, celebrating six decades of advocacy from Österreichische Hämophilie Gesellschaft (ÖHG), the Austrian Haemophilia Society, and learning from their national registry and treatment guidelines.
A powerful session on women’s health and bleeding disorders broke down barriers with discussions on diagnosis, menopausal management, and inspiring patient perspectives from symptomatic carriers.
The afternoon dove deep into von Willebrand Disease, exploring family mental health, the latest in genetics and screening, and a sneak peek at future treatments.
The day wrapped up with our General Assembly, where EHC National Member Organisation representatives came together for important discussions and decisions about our community’s future.
Thank you to our brilliant chairs, speakers, and all attendees. Looking forward to tomorrow’s sessions.”
Keep up with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk